Core Viewpoint - Yu Heng International Investments Corporation and Oriental Keystone Investment Limited are set to publicly auction a total of 99.68 million shares of Yu Heng Pharmaceutical on Taobao from November 20 to November 21, 2025, which may impact the company's stock structure and ownership dynamics [1] Group 1 - Yu Heng International Investments Corporation holds 56.7781 million shares, while Oriental Keystone Investment Limited holds 42.9 million shares, both of which will be auctioned [1] - On November 21, 2025, it was reported that Guo Leifeng, the company's director, general manager, and financial officer, along with his concerted party, Tibet Yupan Enterprise Management Partnership (Limited Partnership), successfully bid for a total of 25 million shares, representing 1.12% of the company's total equity [1]
誉衡药业(002437.SZ)总经理国磊峰及其一致行动人竞拍取得2500万股公司股份